http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4914096-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_421a5ad8d7d7f185b00d3545dbe2e0f6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 |
filingDate | 1989-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1990-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa6560803f19876546d2d77a7e2b6c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4fcfa1f0bd72229129553d0b3578c9 |
publicationDate | 1990-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4914096-A |
titleOfInvention | 6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines |
abstract | The invention discloses certain 6-aryl-substituted-4H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]diazepines useful as PAF inhibitors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method of using such compositions for inhibiting PAF-induced blood platelet aggregation, PAF-mediated bronchoconstriction and extravasation, PAF-induced hypotension, PAF-induced ischemic bowel disease and PAF-mediated, endotoxin induced lung injury, for controlling hyperreactive airways and for protecting against endotoxin-induced hypotension and death. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5104543-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5082839-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5356791-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840721-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5480881-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700826-A |
priorityDate | 1988-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.